|
1
|
Figueroa-Protti L, Soto-Molinari R,
Calderon-Osorno M, Mora J and Alpizar-Alpizar W: Gastric cancer in
the Era of immune checkpoint blockade. J Oncol.
2019(1079710)2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Al-Shibli KI, Donnem T, Al-Saad S, Persson
M, Bremnes RM and Busund LT: Prognostic effect of epithelial and
stromal lymphocyte infiltration in non-small cell lung cancer. Clin
Cancer Res. 14:5220–5227. 2008.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Sudo T, Nishida R, Kawahara A, Saisho K,
Mimori K, Yamada A, Mizoguchi A, Kadoya K, Matono S, Mori N, et al:
Clinical impact of tumor-infiltrating lymphocytes in esophageal
squamous cell carcinoma. Ann Surg Oncol. 24:3763–3770.
2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kang BW, Seo AN, Yoon S, Bae HI, Jeon SW,
Kwon OK, Chung HY, Yu W, Kang H and Kim JG: Prognostic value of
tumor-infiltrating lymphocytes in Epstein-Barr virus-associated
gastric cancer. Ann Oncol. 27:494–501. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kong JC, Guerra GR, Pham T, Mitchell C,
Lynch AC, Warrier SK, Ramsay RG and Heriot AG: Prognostic impact of
tumor-infiltrating lymphocytes in primary and metastatic colorectal
cancer: A systematic review and meta-analysis. Dis Colon Rectum.
62:498–508. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Stanton SE and Disis ML: Clinical
significance of tumor-infiltrating lymphocytes in breast cancer. J
Immunother Cancer. 4(59)2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Germain C, Gnjatic S, Tamzalit F,
Knockaert S, Remark R, Goc J, Lepelley A, Becht E, Katsahian S,
Bizouard G, et al: Presence of B cells in tertiary lymphoid
structures is associated with a protective immunity in patients
with lung cancer. Am J Respir Crit Care Med. 189:832–844.
2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Hennequin A, Derangere V, Boidot R, Apetoh
L, Vincent J, Orry D, Fraisse J, Causeret S, Martin F, Arnould L,
et al: Tumor infiltration by Tbet+ effector T cells and
CD20+ B cells is associated with survival in gastric
cancer patients. Oncoimmunology. 5(e1054598)2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Schweiger T, Berghoff AS, Glogner C,
Glueck O, Rajky O, Traxler D, Birner P, Preusser M, Klepetko W and
Hoetzenecker K: Tumor-infiltrating lymphocyte subsets and tertiary
lymphoid structures in pulmonary metastases from colorectal cancer.
Clin Exp Metastasis. 33:727–739. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Figenschau SL, Fismen S, Fenton KA, Fenton
C and Mortensen ES: Tertiary lymphoid structures are associated
with higher tumor grade in primary operable breast cancer patients.
BMC Cancer. 15(101)2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Sakimura C, Tanaka H, Okuno T, Hiramatsu
S, Muguruma K, Hirakawa K, Wanibuchi H and Ohira M: B cells in
tertiary lymphoid structures are associated with favorable
prognosis in gastric cancer. J Surg Res. 215:74–82. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Helmink BA, Reddy SM, Gao J, Zhang S,
Basar R, Thakur R, Yizhak K, Sade-Feldman M, Blando J, Han G, et
al: B cells and tertiary lymphoid structures promote immunotherapy
response. Nature. 577:549–555. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Cabrita R, Lauss M, Sanna A, Donia M,
Skaarup Larsen M, Mitra S, Johansson I, Phung B, Harbst K,
Vallon-Christersson J, et al: Tertiary lymphoid structures improve
immunotherapy and survival in melanoma. Nature. 577:561–565.
2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Sautès-Fridman C, Lawand M, Giraldo NA,
Kaplon H, Germain C, Fridman WH and Dieu-Nosjean MC: Tertiary
lymphoid structures in cancers: Prognostic value, regulation, and
manipulation for therapeutic intervention. Front Immunol.
7(407)2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Pimenta EM and Barnes BJ: Role of tertiary
lymphoid structures (TLS) in anti-tumor immunity: Potential
tumor-induced cytokines/chemokines that regulate TLS formation in
epithelial-derived cancers. Cancers (Basel). 6:969–997.
2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Carragher DM, Rangel-Moreno J and Randall
TD: Ectopic lymphoid tissues and local immunity. Semin Immunol.
20:26–42. 2008.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Nagtegaal ID, Marijnen CA, Kranenbarg EK,
Mulder-Stapel A, Hermans J, van de Velde CJ and van Krieken JH:
Local and distant recurrences in rectal cancer patients are
predicted by the nonspecific immune response; specific immune
response has only a systemic effect-a histopathological and
immunohistochemical study. BMC Cancer. 1(7)2001.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Guner A and Kim HI: Biomarkers for
evaluating the inflammation status in patients with cancer. J
Gastric Cancer. 19:254–277. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Kosumi K, Baba Y, Ishimoto T, Harada K,
Nakamura K, Ohuchi M, Kiyozumi Y, Izumi D, Tokunaga R, Taki K, et
al: Neutrophil/lymphocyte ratio predicts the prognosis in
esophageal squamous cell carcinoma patients. Surg Today.
46:405–413. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zhang X, Zhang W and Feng LJ: Prognostic
significance of neutrophil lymphocyte ratio in patients with
gastric cancer: A meta-analysis. PLoS One.
9(e111906)2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Haram A, Boland MR, Kelly ME, Bolger JC,
Waldron RM and Kerin MJ: The prognostic value of
neutrophil-to-lymphocyte ratio in colorectal cancer: A systematic
review. J Surg Oncol. 115:470–479. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Gao F, Li X, Geng M, Ye X, Liu H, Liu Y,
Wan G and Wang X: Pretreatment neutrophil-lymphocyte ratio: An
independent predictor of survival in patients with hepatocellular
carcinoma. Medicine (Baltimore). 94(e639)2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Mowbray NG, Griffith D, Hammoda M,
Shingler G, Kambal A and Al-Sarireh B: A meta-analysis of the
utility of the neutrophil-to-lymphocyte ratio in predicting
survival after pancreatic cancer resection. HPB (Oxford).
20:379–384. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Aktas G, Sit M, Dikbas O, Erkol H,
Altinordu R, Erkus E and Savli H: Elevated neutrophil-to-lymphocyte
ratio in the diagnosis of Hashimoto's thyroiditis. Rev Assoc Med
Bras (1992). 63:1065–1068. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Sit M, Aktas G, Erkol H, Yaman S, Keyif F
and Savli H: Neutrophil to lymphocyte ratio is useful in
differentiation of malign and benign thyroid nodules. P R Health
Sci J. 38:60–63. 2019.PubMed/NCBI
|
|
26
|
Duman TT, Aktas G, Atak BM, Kocak MZ,
Erkus E and Savli H: Neutrophil to lymphocyte ratio as an
indicative of diabetic control level in type 2 diabetes mellitus.
African Health Sci. 19:1602–1606. 2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Bilgin S, Aktas G, Zahid Kocak M, Atak BM,
Kurtkulagi O, Duman TT and Savli H: Association between novel
inflammatory markers derived from hemogram indices and metabolic
parameters in type 2 diabetic men. Aging Male. 1–5. 2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Jeong Y, Jeon SR, Kim HG, Moon JR, Lee TH,
Jang JY, Cho JH, Park JS, Park H, Lee KH, et al: The role of
platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in
ulcerative colitis. Intest Res. 19:62–70. 2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Aktas G, Duman T, Atak B, Kurtkulagi O,
Bilgin S, Basaran E, Demirkol ME and Kosekli MA: Irritable bowel
syndrome is associated with novel inflammatory markers derived from
hemogram parameters. Fam Med Prim Care Rev. 22:107–110. 2020.
|
|
30
|
Khoury T, Mari A, Nseir W, Kadah A, Sbeit
W and Mahamid M: Neutrophil-to-lymphocyte ratio is independently
associated with inflammatory activity and fibrosis grade in
nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol.
31:1110–1115. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Fridlender ZG, Sun J, Kim S, Kapoor V,
Cheng G, Ling L, Worthen GS and Albelda SM: Polarization of
tumor-associated neutrophil phenotype by TGF-beta: ‘N1’ versus ‘N2’
TAN. Cancer Cell. 16:183–194. 2009.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Mishalian I, Bayuh R, Levy L, Zolotarov L,
Michaeli J and Fridlender ZG: Tumor-associated neutrophils (TAN)
develop pro-tumorigenic properties during tumor progression. Cancer
Immunol Immunother. 62:1745–1756. 2013.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Hurt B, Schulick R, Edil B, El Kasmi KC
and Barnett C Jr: Cancer-promoting mechanisms of tumor-associated
neutrophils. Am J Surg. 214:938–944. 2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Tokumoto M, Tanaka H, Ohira M, Go Y, Okita
Y, Sakurai K, Toyokawa T, Kubo N, Muguruma K, Maeda K, et al: A
positive correlation between neutrophils in regional lymph nodes
and progression of gastric cancer. Anticancer Res. 34:7129–7136.
2014.PubMed/NCBI
|
|
35
|
Hiramatsu S, Tanaka H, Nishimura J,
Yamakoshi Y, Sakimura C, Tamura T, Toyokawa T, Muguruma K, Yashiro
M, Hirakawa K and Ohira M: Gastric cancer cells alter the
immunosuppressive function of neutrophils. Oncol Rep. 43:251–259.
2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Nakamura K, Yoshida N, Baba Y, Kosumi K,
Uchihara T, Kiyozumi Y, Ohuchi M, Ishimoto T, Iwatsuki M, Sakamoto
Y, et al: Elevated preoperative neutrophil-to-lymphocytes ratio
predicts poor prognosis after esophagectomy in T1 esophageal
cancer. Int J Clin Oncol. 22:469–475. 2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Song Y, Yang Y, Gao P, Chen X, Yu D, Xu Y,
Zhao J and Wang Z: The preoperative neutrophil to lymphocyte ratio
is a superior indicator of prognosis compared with other
inflammatory biomarkers in resectable colorectal cancer. BMC
Cancer. 17(744)2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Fu Y, Liu W, OuYang D, Yang A and Zhang Q:
Preoperative neutrophil-to-lymphocyte ratio predicts long-term
survival in patients undergoing total laryngectomy with advanced
laryngeal squamous cell carcinoma: A single-center retrospective
study. Medicine (Baltimore). 95(e2689)2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Feng Z, Wen H, Bi R, Ju X, Chen X, Yang W
and Wu X: Preoperative neutrophil-to-lymphocyte ratio as a
predictive and prognostic factor for high-grade serous ovarian
cancer. PLoS One. 11(e0156101)2016.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Nayak A, McDowell DT, Kellie SJ and
Karpelowsky J: Elevated preoperative neutrophil-lymphocyte ratio is
predictive of a poorer prognosis for pediatric patients with solid
tumors. Ann Surg Oncol. 24:3456–3462. 2017.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Mori M, Shuto K, Kosugi C, Narushima K,
Hayashi H, Matsubara H and Koda K: An increase in the
neutrophil-to-lymphocyte ratio during adjuvant chemotherapy
indicates a poor prognosis in patients with stage II or III gastric
cancer. BMC Cancer. 18(1261)2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Pang W, Lou N, Jin C, Hu C, Arvine C, Zhu
G and Shen X: Combination of preoperative platelet/lymphocyte and
neutrophil/lymphocyte rates and tumor-related factors to predict
lymph node metastasis in patients with gastric cancer. Eur J
Gastroenterol Hepatol. 28:493–502. 2016.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Nakayama Y, Gotohda N, Shibasaki H, Nomura
S, Kinoshita T and Hayashi R: Usefulness of the
neutrophil/lymphocyte ratio measured preoperatively as a predictor
of peritoneal metastasis in patients with advanced gastric cancer.
Surg Today. 44:2146–2152. 2014.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Tanaka H, Tamura T, Toyokawa T, Muguruma
K, Miki Y, Kubo N, Sakurai K, Hirakawa K and Ohira M: Clinical
relevance of postoperative neutrophil-lymphocyte ratio (NLR) to
recurrence after adjuvant chemotherapy of S-1 for gastric cancer.
Anticancer Res. 38:3745–3751. 2018.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Tanaka H, Muguruma K, Toyokawa T, Kubo N,
Ohira M and Hirakawa K: Differential impact of the
neutrophil-lymphocyte ratio on the survival of patients with stage
IV gastric cancer. Dig Surg. 31:327–333. 2014.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Hiramatsu S, Tanaka H, Nishimura J,
Sakimura C, Tamura T, Toyokawa T, Muguruma K, Yashiro M, Hirakawa K
and Ohira M: Neutrophils in primary gastric tumors are correlated
with neutrophil infiltration in tumor-draining lymph nodes and the
systemic inflammatory response. BMC Immunol. 19(13)2018.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Choi Y, Kim JW, Nam KH, Han SH, Kim JW,
Ahn SH, Park DJ, Lee KW, Lee HS and Kim HH: Systemic inflammation
is associated with the density of immune cells in the tumor
microenvironment of gastric cancer. Gastric Cancer. 20:602–611.
2017.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Tanaka R, Kimura K, Eguchi S, Tauchi J,
Shibutani M, Shinkawa H, Ohira GO, Yamazoe S, Tanaka S, Amano R, et
al: Preoperative neutrophil-to-lymphocyte ratio predicts
tumor-infiltrating CD8(+) T cells in biliary tract cancer.
Anticancer Res. 40:2881–2887. 2020.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Ha SY, Choi S, Park S, Kim JM, Choi GS,
Joh JW and Park CK: Prognostic effect of preoperative
neutrophil-lymphocyte ratio is related with tumor necrosis and
tumor-infiltrating lymphocytes in hepatocellular carcinoma.
Virchows Archiv. 477:807–816. 2020.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Han S, Liu Y, Li Q, Li Z, Hou H and Wu A:
Pre-treatment neutrophil-to-lymphocyte ratio is associated with
neutrophil and T-cell infiltration and predicts clinical outcome in
patients with glioblastoma. BMC Cancer. 15(617)2015.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Kang YK, Boku N, Satoh T, Ryu MH, Chao Y,
Kato K, Chung HC, Chen JS, Muro K, Kang WK, et al: Nivolumab in
patients with advanced gastric or gastro-oesophageal junction
cancer refractory to, or intolerant of, at least two previous
chemotherapy regimens (ONO-4538-12, ATTRACTION-2): A randomised,
double-blind, placebo-controlled, phase 3 trial. Lancet.
390:2461–2471. 2017.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Yamakoshi Y, Tanaka H, Sakimura C, Deguchi
S, Mori T, Tamura T, Toyokawa T, Muguruma K, Hirakawa K and Ohira
M: Immunological potential of tertiary lymphoid structures
surrounding the primary tumor in gastric cancer. Int J Oncol.
57:171–182. 2020.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Sautès-Fridman C, Petitprez F, Calderaro J
and Fridman WH: Tertiary lymphoid structures in the era of cancer
immunotherapy. Nat Rev Cancer. 19:307–325. 2019.PubMed/NCBI View Article : Google Scholar
|
